Pharma Industry News Archive

Pharma Industry News: February 2009

February 2 Pfizer Discontinues Global Phase III Trial of Axitinib for Futility in Advanced Pancreatic Cancer
February 2 Aastrom Phase II IMPACT-DCM Trial Placed On Clinical Hold Pending Review of Isolated Serious Adverse Event
February 2 Federal Trade Commission Files Complaint Against Par Pharmaceutical Over Court-Approved AndroGel Litigation Settlement
February 2 Hollis-Eden Pharmaceuticals Announces Cost-Cutting Measures to Focus Resources on Advancement of Ongoing Clinical Development Programs
February 3 Schering-Plough Reports Financial Results for 2008 Fourth Quarter, Full Year
February 3 Merck Announces Fourth-Quarter and Full-Year 2008 Financial Results
February 3 King Pharmaceuticals Announces Corporate Restructuring to Reduce Operating Expenses
February 3 PharmaNet Development Group Agrees to be Acquired by JLL Partners
February 3 Astellas Announces Global Development Organizational Changes
February 4 Allergan Reports Fourth Quarter 2008 Operating Results and Announces Restructuring
February 4 Early Communication about an Ongoing Safety Review Xigris (Drotrecogin alfa [activated])
February 4 What's the ideal relationship between the drug industry, health professionals and patients?
February 4 Sens. Kohl, Grassley Introduce Bill to Stop Industry 'Payoffs' That Delay Generic Drugs
February 4 University of Maryland School of Medicine and Medical Center Implement New Policies Governing Physician/Industry Relationships
February 4 Strong operating results for Roche in 2008
February 5 GSK Delivers EPS of 104.7p Before Major Restructuring
February 5 Breast Cancer Risk Rapidly Declines After Women Stop Taking Postmenopausal Combined Hormone Therapy
February 6 Vertex Pharmaceuticals Announces Transition in Company Leadership
February 6 Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899 for HIV
February 6 Biogen Idec Reports Full Year and Fourth Quarter 2008 Results
February 6 Biogen Idec Receives Shareholder Proposal
February 6 Avigen Board Rejects BVF Offer as Inadequate
February 6 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and Invega
February 6 Abbott Acquisition of Advanced Medical Optics Clears U.S. Antitrust Review
February 6 Future Pharmaceutical Innovation Requires Patients to be Placed Right at the Centre
February 6 Schering Plough Invests $30 Million in Scottish Facility
February 6 Taro Receives FDA Warning Letter Following Inspection of Its Canadian Manufacturing Facility
February 6 Sudler & Hennessey Expands Montreal Presence
February 9 H. Lundbeck A/S (DK) - Lundbeck to acquire US-based Ovation Pharmaceuticals, Inc.
February 9 KV Pharmaceutical Company Reduces Workforce
February 9 Dynavax Announces Receipt of Communication from the U.S. FDA on HEPLISAV Hepatitis B Vaccine
February 9 GTCR Announces Agreement to Sell Ovation Pharmaceuticals
February 9 Mass. AG Martha Coakley Enters Agreement with Bayer Corporation Resolving Allegations of Deceptive Advertising of Oral Contraceptive
February 10 FDA to Meet with Drug Companies about REMS for Certain Opioid Drugs
February 10 Pfizer to Publicly Disclose Payments to U.S. Physicians, Healthcare Professionals and Clinical Investigators
February 10 Genentech Urges Shareholders to Take No Action With Respect to Unsolicited Tender Offer From Roche
February 10 Roche Commences Tender Offer for Genentech for US$86.50 Per Share in Cash
February 10 New Guidelines for Prescribing Opioid Pain Drugs Published
February 10 FDA to Meet with Drug Companies about REMS for Certain Opioid Drugs
February 10 Enzon Discontinues Further Development of rhMBL
February 10 SK&A Study: More Docs Limit Sales Rep Access
February 10 Significant Shareholder Calls upon Enzon to Immediately Add Two Candidates to the Board of Directors
February 11 FDA and International Serious Adverse Events Consortium Release First Data on Genetic Basis of Adverse Drug Events
February 11 FDA Issues Complete Response Letter for Risperdal Consta for the Adjunctive Maintenance Treatment of Bipolar Disorder
February 11 FDA and Kaplan EduNeering expand alliance
February 11 Sanofi-aventis Delivers 2008 Results Above Guidance
February 11 Strong Fourth Quarter for Genzyme Concludes Productive Year
February 11 Bristol-Myers Squibb Statement on Mead Johnson Nutrition Company IPO
February 12 Bayer Schering Pharma to Invest 100 Million Euro in China to Build a Global R&D Center
February 12 Merck & Co., Inc. Acquires Biologic Manufacturing Capabilities and Developmental Follow-on Biologics Portfolio from Insmed
February 12 Pharmalive.com Launches Medical Device Industry Report
February 12 Portola Pharmaceuticals Enters Worldwide License Agreement for Development and Commercialization of Novel Antiplatelet Drug Elinogrel
February 12 Telik Implements Reorganization to Focus Resources Toward Drug Development Pipeline
February 12 Oscient Pharmaceuticals Restructures Commercial Organization
February 13 Sandoz Receives European Commission Approval For Biosimilar Filgrastim
February 13 Haemacure Restructures - Seeks Financing or Sale of the Company
February 13 Clinicians Using Electronic Prescribing Override Most Medication Safety Alerts
February 13 Spending for Prescription Pain Medicines Has Tripled in 10 Years
February 13 Novogen to Focus on Oncology Program
February 13 ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
February 17 FDA Approves ULORIC (febuxostat) for the Chronic Management of Hyperuricemia in Patients with Gout
February 17 Hospira Reports Fourth-Quarter and Full-Year 2008 Results
February 17 Teva Reports Record Full Year 2008 and Fourth Quarter Results
February 17 Synta Earns $10 Million from GlaxoSmithKline for Achieving Elesclomol Milestone
February 17 Merck Sharp & Dohme Ltd Withdraws Its Marketing Authorisation Application For Vorinostat MSD (Vorinostat)
February 17 Doctors' Resources for Off-Label Prescribing May Be Incomplete, Unclear
February 17 Teva Provides 2009 Financial Outlook
February 18 CSL Limited announce Half-Year Results for 2008/09
February 18 Merck KGaA: 2008 Operating Result Rises 16% to € 1,131 Million
February 18 Type of Rheumatoid Arthritis Medication May be Associated With Increased Risk for Shingles
February 18 GPC Biotech and Agennix Announce Proposed Merger
February 18 Cipher receives tentative FDA approval for extended-release tramadol capsules
February 18 Jury Finds Pharmacia Committed Fraud On Wisconsin Medicaid Program; Van Hollen’s Department Of Justice Wins State $9 Million
February 19 Shire Delivers Excellent Growth for the Year, with the New Product Portfolio Achieving Sales of $1 Billion
February 19 Solvay: 2008 Operating Result (EUR 965 Million) Down By 19% Compared To The Record Result of 2007
February 19 Sanofi-Aventis U.S. Launches Diabetes-Focused YouTube Channel
February 19 European Commisssion Grants Ferring Pharmaceuticals Approval of Firmagon (Degarelix) for Treatment of Prostate Cancer
February 19 European Medicines Agency Recommends Suspension of Marketing Authorization for Raptiva
February 19 FDA Public Health Advisory: Updated Safety Information about Raptiva (efalizumab)
February 19 United States Joins Suits Against Scios and Johnson & Johnson
February 19 European Medicines Agency recommends continued vaccination with Gardasil
February 19 European Medicines Agency recommends new contraindication and warning for Rasilez and other aliskiren medicines
February 19 Dallas Scientists Discover Statins May Falsely Indicate Thyroid Problems
February 19 La Jolla Pharmaceutical Company Announces Reduction in Workforce and Evaluates Strategic Options
February 20 CV Therapeutics Reports 2008 Fourth Quarter and Full Year Financial Results
February 20 CV Therapeutics' Board of Directors Rejects Astellas Unsolicited Proposal
February 20 Schering-Plough Submits Response to FDA for SAPHRIS (asenapine) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder
February 20 UCB (BE) - UCB to Divest Equasym
February 20 Shire to Enter European ADHD Market With the Acquisition of Equasym IR and XL
February 20 Questions of Ethics and Quality Cloud Globalization of Clinical Trials
February 20 House Committee on Energy and Commerce Chairmen Waxman and Stupak Request Study Data for Vytorin
February 20 Daiichi Sankyo Notice on Organizational Restructuring as of April 1, 2009
February 20 Discontinuation of Development of TAK-242 for Severe Sepsis
February 20 Shire Announces Opening of Office in Japan
February 20 Neuralstem's ALS Trial on Clinical Hold
February 23 Abbott Receives European Commission Clearance on Acquisition of Advanced Medical Optics
February 23 Astellas Pharma Issues Statement Regarding CV Therapeutics Rejection of All-Cash Proposal
February 23 European Commission Approves EFIENT (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI
February 23 AstraZeneca Announces SEROQUEL XR is Now Available to Treat Bipolar Depression
February 23 Patient Knowledge of Health Information Influences Cancer Treatment
February 23 Two FDA Quality Systems Compliance Resources Published
February 23 MedWatch - Zonisamide (marketed as Zonegran, and generics) Can Cause Metabolic Acidosis in Some Patients
February 24 Genentech Announces March 2, 2009 Webcast of Investment Community Meeting
February 24 Genentech Special Committee Rejects Roche's $86.50 Offer as Inadequate
February 24 Panacos Provides Corporate and Strategic Update
February 24 AstraZeneca's Partner, MAP Pharmaceuticals, Announces Phase 3 Study of Unit Dose Budesonide in Children with Asthma Did Not Meet Primary Endpoints
February 24 Basilea Pharmaceutica Ltd. (CH) - Basilea Pharmaceutica Files Claims Against Johnson & Johnson Over Its Handling of Ceftobiprole (ZEFTERA/Zevtera) Clinical Studies
February 24 Basilea Pharmaceutica Ltd. (CH) - Zevtera Review Process Delayed in EU
February 24 Orion Corporation (FI) - Orion: Primary Objective of STRIDE-PD Study Was Not Achieved
February 24 Pfizer Discontinues Development of Two Phase 3 Compounds
February 24 US Physicians Sharply Increase Their Negative Word of Mouth about Pharma, with EU Doctors Also Expressing High Dissatisfaction
February 25 Elan Announces Further Alignment of Resources as Part of On-Going Strategic Review Process
February 25 Abbott Successfully Completes Tender Offer for Shares of Advanced Medical Optics
February 25 Smaller, Refocused Salesforce Will Enable Pharmaceutical Companies to Create Greater Value for Patients, Says New PricewaterhouseCoopers Report
February 25 Press Statement Issued by Ranbaxy Laboratories Limited
February 25 United States Files Complaint Against Forest Laboratories for Allegedly Violating the False Claims Act
February 25 Trubion Pharmaceuticals Inc. Announces Work-Force Reductions and Restructuring
February 26 FDA Takes New Regulatory Action Against Ranbaxy’s Paonta Sahib Plant in India
February 26 Forest Laboratories, Inc. Provides Statement in Response to Complaint Filed by U.S. Government
February 26 King Pharmaceuticals Reports Year-End and Fourth-Quarter 2008 Financial Results
February 26 Parents Learn About HPV Vaccine Mostly from Drug Company Ads
February 27 Endo Pharmaceuticals Returns Product Rights to Transdur-Sufentanil to Durect
February 27 FDA Sends Letter to GlaxoSmithKline Over Avodart Ad
February 27 Synta Suspends Elesclomol SYMMETRYTrial in Metastatic Melanoma
February 27 FDA Requires Boxed Warning and Risk Mitigation Strategy for Metoclopramide-Containing Drugs
February 27 Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease
February 27 Astellas Files Lawsuit Against CV Therapeutics

Pharma Industry News Archive

2009: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

MedNotes
Advertisement

(web4)